Dihydrothiazine prodrugs of thiazolium agents
Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted u...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Reinhard, Emily Katten, Elliot |
description | Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07511036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07511036</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075110363</originalsourceid><addsrcrecordid>eNrjZNB1ycyoTCnKL8nITKzKzEtVKCjKTykqTS9WyE9TAAvm52SW5iokpqfmlRTzMLCmJeYUp_JCaW4GBTfXEGcP3dLigsQSkIr49KJEEGVgbmpoaGBsZkyEEgDr_Suy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dihydrothiazine prodrugs of thiazolium agents</title><source>USPTO Issued Patents</source><creator>Reinhard, Emily ; Katten, Elliot</creator><creatorcontrib>Reinhard, Emily ; Katten, Elliot ; Synvista Therapeutics, Inc</creatorcontrib><description>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7511036$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7511036$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Katten, Elliot</creatorcontrib><creatorcontrib>Synvista Therapeutics, Inc</creatorcontrib><title>Dihydrothiazine prodrugs of thiazolium agents</title><description>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNB1ycyoTCnKL8nITKzKzEtVKCjKTykqTS9WyE9TAAvm52SW5iokpqfmlRTzMLCmJeYUp_JCaW4GBTfXEGcP3dLigsQSkIr49KJEEGVgbmpoaGBsZkyEEgDr_Suy</recordid><startdate>20090331</startdate><enddate>20090331</enddate><creator>Reinhard, Emily</creator><creator>Katten, Elliot</creator><scope>EFH</scope></search><sort><creationdate>20090331</creationdate><title>Dihydrothiazine prodrugs of thiazolium agents</title><author>Reinhard, Emily ; Katten, Elliot</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075110363</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Katten, Elliot</creatorcontrib><creatorcontrib>Synvista Therapeutics, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Reinhard, Emily</au><au>Katten, Elliot</au><aucorp>Synvista Therapeutics, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dihydrothiazine prodrugs of thiazolium agents</title><date>2009-03-31</date><risdate>2009</risdate><abstract>Provided are compounds of the formula (and pharmaceutically acceptable salts thereof): wherein: Also provided are pharmaceutical compositions containing the compounds, and methods for the preparation of the compounds. The compounds are useful, among other things, as prodrugs which can be converted under acidic conditions to thiazolium agents. The compounds can be administered to mammals, including humans, for treatment of various indications.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07511036 |
source | USPTO Issued Patents |
title | Dihydrothiazine prodrugs of thiazolium agents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A51%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Reinhard,%20Emily&rft.aucorp=Synvista%20Therapeutics,%20Inc&rft.date=2009-03-31&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07511036%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |